The France heparin Market relates to the demand for heparin (an anticoagulation drug) in the healthcare market in France. It includes the sales and utilization of heparin products sold to hospitals, clinics, and pharmacies to treat and/or prevent blood clots. The market as a whole may be influenced by different parameters as the prevalence of cardiovascular disease, an increasing aging population, and increasing use of heparin-coated. The market is poised for growth because of increasing usage of blood products, increasing geriatric population, and increasing usage of plasma transfusions in industries, like the pharmaceutical industry.